Haemonetics Corp.

Haemonetics is a healthcare company. The company has three product categories: Plasma, which includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers; Blood Center, which includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software; and Hospital, which is comprised of Hemostasis Management and Cell Processing products, includes devices and methodologies for measuring coagulation characteristics of blood, surgical blood salvage systems, blood cell processing systems, disposables and blood transfusion management software.
  • TickerHAE
  • ISINUS4050241003
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

HAEMONETICS CORP. reduced its risk exposure resulting in an upgrade to Slightly Positive

HAEMONETICS CORP. (US), a company active in the Medical Equipment industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 1 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date November 19, 2019, the closing price was USD 120.84 and its potential was estimated at USD 142.90.

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

1 director sold after exercising options/sold

A director at Haemonetics Corp sold after exercising options/sold 3,646 shares at 112.490USD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under lis...

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

HAEMONETICS CORP. reduced its risk exposure resulting in an upgrade to Slightly Positive

HAEMONETICS CORP. (US), a company active in the Medical Equipment industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 1 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date November 19, 2019, the closing price was USD 120.84 and its potential was estimated at USD 142.90.

ValuEngine Rating and Forecast Report for HAE

ValuEngine Rating and Forecast Report for HAE

MarketLine Department

Fresenius SE & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Fresenius SE & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Fresenius SE & Co. KGaA since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive ad...

GlobalData Department

Haemonetics Corp (HAE) - Medical Equipment - Deals and Alliances Profile

Summary Haemonetics Corp (Haemonetics) is a healthcare company that offers blood management technologies and software solutions. Its portfolio includes integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite of solutions to the blood supply chain, which ranges from plasma and blood collectors to hospitals. Haemonetics markets its products to blood collection groups and independent blood centers, national health organizations, hospital service providers, hospitals, group purchasing organizations, and bio...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: Many health care names are staging reversals and breaking above bullish bases, including IVC, CUTR, VREX, EHC, SEM, AMED, MD, HAE, RGEN, BIO, LCI, PBH, Semiconductor and semi-suppliers continue to be leadership (ex. ACLS, VECO, COHU, QRVO, SWKS, SYNA, CRUS, SMTC, QCOM) A number of auto component suppliers appear to be bottoming (ex. AXL, DAN, BWA)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Homebuilders continue to outperform. (ex. LGIH, CCS, MDC, DHI, MTH, KBH, and KBH) • A few Consumer Discretionary names are attractive. (ex. DECK, AZO, TGT, OLLI, and HIBB.) • The Financial Sector continues to have positively developing technical patterns. (STL, CASH, WRLD, FCFS, NAVI, COF, and RJF)

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch